The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
By 2030, How Much Growth In Market Size Is Expected For The Hospital Acquired Infections Testing Kits Market?
Significant expansion has been observed in the hospital acquired infections testing kits market size during recent years. This market is projected to grow from $4.79 billion in 2025 to $5.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. The historical rise in this market can be attributed to elements such as increasing hospital infection surveillance, the escalating prevalence of antibiotic-resistant pathogens, the enlargement of clinical microbiology laboratories, the implementation of infection control protocols, and the widespread availability of molecular diagnostic tools.
The hospital acquired infections testing kits market is projected to experience substantial expansion in the coming years. This market is set to reach a valuation of $7.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. Factors driving this growth during the projected period include a heightened emphasis on prompt infection identification, increased capital allocation for hospital safety infrastructure, the wider embrace of rapid testing methods, an escalating need for automated diagnostic processes, and innovations in molecular diagnostics technology. Key trends anticipated over the forecast period encompass the surging acceptance of rapid diagnostic test kits, a greater reliance on molecular testing for HAIs, the increasing incorporation of automated diagnostic equipment, the broadening scope of point-of-care infection testing, and a sharpened focus on detecting multiple pathogens.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp
Which Drivers Are Advancing The Hospital Acquired Infections Testing Kits Market Growth?
The expansion in the number of healthcare settings is anticipated to fuel the growth of the hospital-acquired infections testing kits market in the future. Within these settings, a broad spectrum of healthcare facilities and services, such as acute care hospitals, urgent care centers, rehabilitation facilities, nursing homes, and long-term care facilities, are available, providing extensive healthcare options. Hospital-acquired infections testing kits serve as essential instruments for identifying and preventing healthcare-associated infections, thereby improving patient safety within these healthcare environments. For example, data from May 2023, cited by the American Hospital Association, a US-based healthcare industry trade group, indicates a notable increase in the total number of hospitals across the U.S. region, climbing from 6,093 in 2022 to 60,129 in 2023. Concurrently, admissions in community hospitals also expanded, rising from 31,393,318 in 2022 to 31,967,073 in 2023. Consequently, the growing prevalence of healthcare settings is a key driver for the hospital-acquired infections testing kits market.
What Key Segment Areas Are Included In The Hospital Acquired Infections Testing Kits Market Assessment?
The hospital acquired infections testing kits market covered in this report is segmented –
1) By Product: Consumables And Reagents, Instruments
2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others
3) By Pathogen Type: Viral, Bacterial, Fungal
4) By Application: Drug Resistance Testing, Disease Testing
Subsegments:
1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)
2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)
Which Trends Are Guiding The Development Of The Hospital Acquired Infections Testing Kits Market?
Leading companies in the hospital-acquired infections (HAI) testing kits market are concentrating on developing advanced point-of-care antimicrobial susceptibility testing (AST) solutions to enable rapid diagnosis, guide targeted therapy, and combat antimicrobial resistance (AMR). Point-of-care AST employs proprietary microfluidic technology to quickly identify bacterial presence and evaluate antibiotic effectiveness directly from patient urine samples, thereby reducing diagnostic delays and improving treatment decisions. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, unveiled the world’s first point-of-care testing system in Europe capable of executing antimicrobial susceptibility testing in just 30 minutes. Utilizing a microfluidic-based AST approach for patients with suspected urinary tract infections, the system significantly decreases turnaround time and supports antimicrobial stewardship in primary care settings by allowing for timely and informed antibiotic use, thus contributing to global efforts to curb AMR.
Which Key Players Are Active In The Hospital Acquired Infections Testing Kits Market?
Major companies operating in the hospital acquired infections testing kits market are Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, Vivacheck Lab
Access The Complete Hospital Acquired Infections Testing Kits Market Report:
Which Regional Market Leads The Hospital Acquired Infections Testing Kits Market?
North America was the largest region in the hospital-acquired infections testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Hospital Acquired Infections Testing Kits Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2026, By The Business Research Company
Viral Diagnostic Test Kits Market Report 2026
https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report
Infection Control Supplies Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report
Hospital Acquired Infection Control Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model